Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer
Clinical trial NCT01620515 · COMPLETED
Trial details
- NCT number
- NCT01620515
- Sponsor
- Nymox Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-21
- Primary completion
- 2015-10-21
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.